STAT
JULY 3, 2025
Last fall, a group of experts advising the U.S. Food and Drug Administration debated for two days on how to regulate generative artificial intelligence tools in medicine. One report presented at the meeting showed that a generative AI tool supposedly used by 40% of the radiology practices in the U.S. produced clinically significant errors in one of every 21 reports.
NY Times
JULY 3, 2025
More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings for the federal government.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JULY 3, 2025
Recently, the Department of Health and Human Services floated new standards for vaccine approvals, rescinded longstanding Covid-19 vaccine recommendations for healthy children and pregnant women, and fired all 17 members of the Centers for Disease Control and Prevention’s vaccine advisory committee. These actions represent a significant shift in the federal government’s approach to vaccine policy and the safeguarding of the public’s health.
The Pharmacist
JULY 3, 2025
The government has pledged to ‘transition’ community pharmacy from a dispensing-focused service to offering more clinical services, as part of its long-awaited NHS 10-year plan. Published today, the 168-page blueprint has committed to increasing the role of community pharmacy in the management of long-term conditions, including treatment of obesity, high blood pressure and high cholesterol. […] The post Pharmacies’ clinical services offering to expand under NHS 10-year plan appeared first
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
JULY 3, 2025
There’s been much discussion and debate about the cuts to Medicaid eligibility that Congress just passed and, in particular, what they may mean for current Medicaid recipients. A key piece of evidence in this debate has been results from the Oregon Health Insurance Experiment (OHIE ), a randomized trial, which I helped lead, examining the impact of covering low-income uninsured adults with Medicaid for one to two years.
Beckers Hospital Review
JULY 3, 2025
Weeks into his new role as president and CEO of Bryn Mawr, Pa.-based Main Line Health, Edward Jimenez told Becker’s the five-hospital system — with more than 13,000 employees — is taking steps to stay financially resilient while also hiring more physicians and planning new care sites to improve access. Mr. Jimenez assumed the top leadership role in June and brings nearly 30 years of healthcare leadership experience.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Beckers Hospital Review
JULY 3, 2025
From detecting cancer and remote patient monitoring to streamlined documentation and automated prior authorizations, here are 15 proven clinical uses of AI — with results: Nearly 2,000 physicians and advanced practice providers at Altamonte Springs, Fla.-based AdventHealth are using Nuance’s DAX Copilot ambient AI scribe. Since implementing the technology in April 2024, 86% of users report less burnout, 83% report improved work-life balance and job satisfaction, 80% report better patient e
STAT
JULY 3, 2025
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: MoonLake Immunotherapeutics : Results from the sonelokimab Phase 3 VELA studies in hidradenitis suppurativa. Cogent Biosciences : Readout in July from the bezuclastinib Phase 3 SUMMIT study in indolent systemic mastocytosis.
Express Pharma
JULY 3, 2025
Biocon Biologics announced that the European Commission (EC) has granted marketing authorisation in the European Union (EU) for Vevzuo and Evfraxy biosimilars of Denosumab. Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand). RANKL plays a crucial role in the formation, function, and survival of osteoclasts, which are the cells responsible for bone resorption.
European Pharmaceutical Review
JULY 3, 2025
Embedded as the cornerstone of microbiological quality are processes that have remained the same for over a century, unchanged from their early beginnings. To achieve optimal detectability and considerably lower risk to patients, the traditional sterility test requires a minimum of 14 days of incubation, and sometimes even longer if the test sample renders media turbid and subculturing is required to overcome visual interference.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Beckers Hospital Review
JULY 3, 2025
Every nine and a half minutes, Tampa (Fla.) General Hospital receives a new patient in its emergency department. Its academic medical center has 1,045 beds and is expanding to nearly 1,200 beds with construction on a new patient tower underway. Regardless of a hospital or health system’s size, President and CEO John Couris sees care coordination as one of the most pressing challenges in healthcare.
Express Pharma
JULY 3, 2025
Key takeaways: Sharp decline in funding: Funding dramatically decreased in June 2025, falling over 97 per cent from the previous month and over 96 per cent from the same month last year. Early-stage rounds dominate: Unlike previous periods, early-stage investments made up the largest share of funding in June at 65.1 per cent, surpassing seed-stage funding.
Beckers Hospital Review
JULY 3, 2025
Becker’s has reported on 18 hospital and emergency department closures in 2025: Editor’s note: This article will be updated continuously. 1. Rockford, Ill.-based Javon Bea Hospital-Rockton has closed after Rockford-based Mercyhealth filed a “temporary suspension of services” with the state. 2. St. Louis-based St. Luke’s Des Peres Hospital, a 143-bed acute care facility, will close on Aug. 1 due to low utilization and increased financial pressures. 3.
Pharmafile
JULY 3, 2025
Ferring Pharmaceuticals has reported that a conventional 15µg/day starting dose of follitropin delta (Rekovelle) provides comparable efficacy and safety to a standard 225IU/day dose of follitropin alfa in women undergoing ovarian stimulation for fertility treatments: in vitro fertilisation or intracytoplasmic sperm injection. This reinforces the clinical evidence base for follitropin delta, the only recombinant follicle-stimulating […] The post Ferring strengthens evidence for flexible dos
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Beckers Hospital Review
JULY 3, 2025
A number of hospitals and health systems are reducing their workforces or jobs amid financial and operational challenges. Below are workforce reduction efforts or job eliminations announced in 2025. Editor’s Note: This webpage was created Jan. 22 and updated on July 3. July 1. San Diego-based Sharp HealthCare will reduce its workforce and enact other cost-cutting measures, citing the industry’s challenging economic conditions.
The Pharmacist
JULY 3, 2025
Community pharmacies will be able to provide the HPV vaccine from 2026 to those who missed out at school, according to the government’s 10-year health plan, published today. The long-awaited plan also committed to giving community pharmacy a ‘bigger role’ in prevention by expanding responsibilities for delivering vaccines and screening for cardiovascular and diabetes risks. […] The post Community pharmacies can provide HPV vaccination from 2026 appeared first on The Pharmacist.
Beckers Hospital Review
JULY 3, 2025
Artificial intelligence is reshaping healthcare. For many frontline workers, the technology feels abstract, opaque or out of reach. But once they’re equipped with AI literacy education, health systems experience a renaissance of possibilities. Peter Chang, MD, senior vice president and chief transformation officer at Tampa General Hospital, believes that closing this knowledge gap is one of the most urgent challenges facing health systems today.
STAT
JULY 3, 2025
This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I’m not sure if this newsletter is beach-reading material, but I hope you enjoy the long July Fourth weekend, wherever you’re taking it. And if you want to look ahead to what’s coming this quarter, my third quarter scorecard is out.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Express Pharma
JULY 3, 2025
Parexel announced two Food and Drug Administration (FDA) luminaries have joined Parexel’s Consulting team – Dr Lola Fashoyin-Aje, Sr VP, Head of Regulatory Oncology, Cell & Gene, and Dr Tala Fakhouri, VP Consulting, AI & Digital Policy, Real-World Research. These strategic appointments will bolster the company’s regulatory expertise and add senior leaders to a Consulting team that supported nearly one-third of all sponsor NDA/BLA submissions approved by FDA in 2024, informs a statement f
Beckers Hospital Review
JULY 3, 2025
A new study projects that aligning U.S. cholesterol treatment with clinical guidelines could significantly reduce cardiovascular events nationwide. The study, led by researchers at Baltimore-based Johns Hopkins University and Merck and published June 30 in the Journal of General Internal Medicine , used data from nearly 5,000 adults 40-75 who participated in the National Health and Nutrition Examination Survey between 2013 and 2020.
NY Times
JULY 3, 2025
Alcohol can present health problems for even light or occasional drinkers.
pharmaphorum
JULY 3, 2025
Dizal gets US approval for an oral therapy for EGFR exon 20-mutated NSCLC, offering some patients an alternative to J&J's intravenous Rybrevant
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Big Molecule Watch
JULY 3, 2025
In its June 2025 meeting, the European Medicines Agency’s (“EMA”) Committee for Medicinal Products for Human Use (“CHMP”) adopted positive opinions for six biosimilar medicines. The medicines include four aflibercept products (Mynzepli, Afiveg, Vgenfli and Eiyzey), one ustekinumab product (Usymro), and one pegfilgrastim product (Vivlipeg). Additionally, on June 23, 2025, Alvotech announced that the EMA adopted a positive opinion recommending market approval of AVT06.
pharmaphorum
JULY 3, 2025
Regeneron's bid to join the crowded US market for BCMA-targeted bispecific antibodies for multiple myeloma has finally been realised
Beckers Hospital Review
JULY 3, 2025
Epic strengthened its international position in the global hospital EHR market in 2024, according to a new report from healthcare research firm KLAS. The report, “Global Acute Care EHR Market Share 2025” is based on EHR sales in 2024 confirmed by KLAS. The firm validated regional decisions in Austria, Canada, France, Mauritius, Saudi Arabia and the United Kingdom.
European Pharmaceutical Review
JULY 3, 2025
New data from an ongoing study shows that a synthetic adeno-associated virus (AAV)-based gene therapy can improve hearing in individuals with congenital condition autosomal recessive deafness 9. It evaluated ten participants aged between one and 24 years old with a genetic form of deafness or severe hearing impairment caused by OTOF gene mutations. This results in otoferlin deficiency, a protein with a key role in transmitting auditory signals from the ear to the brain.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Pharmacist
JULY 3, 2025
Some 44% of adults support the NHS making weight loss injections free through their community pharmacy, new polling commissioned by the National Pharmacy Association (NPA) has found. This figure rose to 55% among those aged 16 to 34 years old, according to the survey of 2,002 UK adults carried out by market research company Savanta. […] The post Almost half of adults support free weight loss jabs through pharmacy, shows poll appeared first on The Pharmacist.
Pharmaceutical Commerce
JULY 3, 2025
Bruce Leuchter, CEO, Neurvati, discusses why patient engagement is essential to understanding rare diseases and driving the development of breakthrough therapies.
pharmaphorum
JULY 3, 2025
Is AstraZeneca about to join the ranks of pharma companies spending big bucks on PD(L)-1xVEGF bispecific antibodies for cancer?
Pharmaceutical Commerce
JULY 3, 2025
The company joins a wave of global pharma companies reshoring operations to strengthen the US supply chain and meet patient needs through domestic innovation and capacity.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
318 
Let's personalize your content